Why did Moody’s downgrade US credit rating?
How will tariffs impact US and European economy?
What caused 23andMe bankruptcy and acquisition?
Why is Nvidia expanding AI infrastructure in Taiwan?
How will Capital One’s Discover acquisition affect customers?
What’s behind the comeback of SPAC deals?
Why did CBS News CEO resign amid Trump lawsuit?
How are mortgage rates reacting to US credit downgrade?
What’s driving recent volatility in Bitcoin and crypto?
Regeneron is buying 23andMe out of bankruptcy for $256 million
fortune.com/article/regeneron-23andme-bankruptcy-256-million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
In March 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved…
This story appeared on fortune.com, 2025-05-19 14:20:44.